Stay updated with breaking news from Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Government recently announced steps towards extending free breast cancer screening to women aged 70-74. Clinical lead for BreastScreen Aotearoa, Dr Adam...
Would be swayed by a guilty verdict are few and far in between, and if the court does render a not guilty verdict, that would be a enormous boom for trump because he could frame it as an exoneration, like his two impeachment trials before that. Interesting, some interesting times ahead, thank you for your time, thomas. ,. , ahead, thank you for your time, thomas. ,. , the head of israeli Military Intelligence, aharon haliva, has resigned the first senior israeli official to step down over the hamas attacks on october 7th. Mr haliva has accepted responsibility for the Military Intelligence fail...
Corner Therapeutics Inc. raised $54 million in a series A financing to create vaccines to protect against cancer and infectious diseases by helping the immune system engineer T cells. The company’s core interest is in advancements in immunotherapy through direct manipulation of T cells, which are the “keys to the kingdom for any cancer therapy,” Nick Seaver, Corner’s chief business officer, told BioWorld.
Cerevel Therapeutics Inc.’s positive results from the long-shot pivotal phase III Tempo-3 trial with tavapadon – the first D1/D5 receptor partial agonist being studied as a once-daily treatment for Parkinson’s disease – added gravy to the $8.7 billion takeover by Abbvie Inc., disclosed late last year. The buyout’s centerpiece was the late-stage asset emraclidine, a positive allosteric modulator of the muscarinic M4 receptor, touted as a potential best-in-class, next-generation antipsychotic for schizophrenia, which strikes more than 5 million people in the G7 (U.S., France, Germany, ...
Wait times for an appointment at Katikati Medical Centre (KMC) can be weeks long and while a new doctor should help the situation, the centre’s clinical...